SG11202105172PA - Biomarkers for cardiovascular events - Google Patents

Biomarkers for cardiovascular events

Info

Publication number
SG11202105172PA
SG11202105172PA SG11202105172PA SG11202105172PA SG11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA SG 11202105172P A SG11202105172P A SG 11202105172PA
Authority
SG
Singapore
Prior art keywords
biomarkers
cardiovascular events
cardiovascular
events
Prior art date
Application number
SG11202105172PA
Inventor
Mika Hilvo
Reijo Laaksonen
Original Assignee
Zora Biosciences Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zora Biosciences Oy filed Critical Zora Biosciences Oy
Publication of SG11202105172PA publication Critical patent/SG11202105172PA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04Phospholipids, i.e. phosphoglycerides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08Sphingolipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202105172PA 2018-12-06 2019-12-06 Biomarkers for cardiovascular events SG11202105172PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862776272P 2018-12-06 2018-12-06
PCT/EP2019/084008 WO2020115288A1 (en) 2018-12-06 2019-12-06 Biomarkers for cardiovascular events

Publications (1)

Publication Number Publication Date
SG11202105172PA true SG11202105172PA (en) 2021-06-29

Family

ID=68808396

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105172PA SG11202105172PA (en) 2018-12-06 2019-12-06 Biomarkers for cardiovascular events

Country Status (8)

Country Link
US (1) US20220003791A1 (en)
EP (1) EP3891509A1 (en)
JP (1) JP2022508322A (en)
KR (1) KR20210100679A (en)
CN (1) CN113396334A (en)
CA (1) CA3122035A1 (en)
SG (1) SG11202105172PA (en)
WO (1) WO2020115288A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
EP4043884A1 (en) 2021-02-10 2022-08-17 Eberhard-Karls-Universität Tübingen Medium-chain fatty acyls and phospholipids as biomarkers for cardiovascular diseases
US11735303B2 (en) * 2021-06-22 2023-08-22 David Haase Apparatus and method for determining a composition of a replacement therapy treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9066939B2 (en) * 2009-11-17 2015-06-30 Baylor Research Institute Urinary triaosylceramide (GB3) as a marker of cardiac disease
ES2455124T5 (en) * 2010-05-05 2018-05-08 Zora Biosciences Oy Lipidomic biomarkers for atherosclerosis and heart disease
CN103154742B (en) 2010-06-20 2017-11-21 佐拉生物科学公司 For identifying the iipidomic mark of excessive risk patients with coronary artery disease
EP2592422A1 (en) 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
EP2592423A1 (en) 2011-11-08 2013-05-15 Zora Biosciences OY Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
US20160018423A1 (en) * 2013-03-08 2016-01-21 Zora Biosciences Oy Non-high density lipoprotein derived cvd markers
KR101565889B1 (en) * 2014-04-23 2015-11-06 연세대학교 산학협력단 Methods for Predicting or Determining Arterial Stiffness Using plasma metabolites
US9347960B2 (en) * 2014-06-16 2016-05-24 Zora Biosciences, Oy Ceramides and their use in diagnosing CVD
CA3013316A1 (en) * 2016-02-04 2017-08-10 Metanomics Gmbh Means and methods for differentiating between heart failure and pulmonary disease in a subject

Also Published As

Publication number Publication date
JP2022508322A (en) 2022-01-19
CA3122035A1 (en) 2020-06-11
CN113396334A (en) 2021-09-14
US20220003791A1 (en) 2022-01-06
WO2020115288A1 (en) 2020-06-11
KR20210100679A (en) 2021-08-17
EP3891509A1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
SG11202105172PA (en) Biomarkers for cardiovascular events
GB201704267D0 (en) Novel biomarker
GB201703058D0 (en) Biomarkers
GB2596456B (en) Immunoassay for mitragynine
GB201908780D0 (en) Melanoma biomarkers
GB201902077D0 (en) Biomarkers
GB201911947D0 (en) Miscarriage biomarkers
GB201804648D0 (en) Combination biomarker
GB201703123D0 (en) Biomarkers
GB201900677D0 (en) Biomarkers
GB201909228D0 (en) Screen for inhibitors
GB201814807D0 (en) Dementia Biomarkers
GB201811093D0 (en) Biomarker
GB201706064D0 (en) Biomarkers for glucocorticoid action
SG11202110589PA (en) Biomarkers for selinexor
EP3807614C0 (en) Microtome
PL3894133T3 (en) An electrospindle
PT3894132T (en) An electrospindle
GB201915228D0 (en) Biomarkers
GB201902070D0 (en) Biomarkers
GB201914183D0 (en) Biomarker
GB201913846D0 (en) Biomarker
GB201913612D0 (en) Biomarker
GB201912154D0 (en) Biomarker
GB201911078D0 (en) Biomarker